Winter Innovations, Inc. — SEC Form D Filing
Winter Innovations, Inc. filed an SEC Form D on September 1, 2026, reporting $1.26M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 1, 2026
- Amount reported
- $1.26M
- Round stage
- Seed
- Industry
- Medical Devices
- Website
- https://www.winter-innovations.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Current orthopedic surgical stitching methods can be inefficient, cause more needle holes, lead to tissue shredding, and require more suture material, impacting reliability for surgeons and patients.
Solution
Winter Innovations develops medical devices, including a patented two-part needle technology (EasyWhip®) and advanced stitching solutions (WhipLock™), designed to make orthopedic surgical stitching more efficient, reliable, and to minimize tissue damage during procedures like tendon and ligament repair.
Why now
Advances in medical technology and a demand for improved surgical outcomes and efficiency in orthopedic procedures drive the need for innovative suturing and graft preparation tools.
Verdict
This cleared because investors saw a patented, incremental efficiency gain in a high-stakes, well-funded medical procedure, not because the company was disrupting an entire market. They were implicitly betting on the clinical efficacy proving out for orthopedic surgeons and the sales team's ability to navigate established hospital procurement channels. Upside was limited by the specialized nature of the surgical niche and the long sales cycles inherent in medical device adoption, which often slows revenue acceleration.
Source: SEC EDGAR Form D filing